SCHEMBL2352992

SCHEMBL2352992

O=C(CC(F)(F)F)N(C(=O)[C@@H]1C[C@@H](Cc2ccccc2)CN1)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
HRH3 Q9Y5N1 3/20 0.37
OPRM1 P35372 5/20 0.36
S1PR1 P21453 3/20 0.36
CYP2D6 P10635 2/20 0.36
CYP3A4 P08684 1/20 0.36
NR3C1 P04150 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP2C9 P11712 2/20 0.34
LTA4H P09960 1/20 0.33
EPHX2 P34913 1/20 0.33
MMP2 P08253 1/20 0.33
RNF4 P78317 1/20 0.33
MASP2 O00187 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2353030 0.86 OPRM1 (0.37) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2352603 0.86 POLB (0.38) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2354130 0.85 OPRM1 (0.38) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2357176 0.84 HRH3 (0.37) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2350633 0.83 OPRM1 (0.39) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2352589 0.81 POLB (0.37) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2172637 0.80 GSK3A (0.38) MEN1POLBKMT2AHRH3OPRM1
SCHEMBL2169856 0.78 CYP2C9 (0.45) HRH3OPRM1S1PR1CYP2D6CYP3A4
SCHEMBL3122969 0.77 CYP2C9 (0.40) HRH3OPRM1S1PR1CYP2D6CYP2C9
SCHEMBL2172041 0.77 CYP2C9 (0.40) HRH3OPRM1S1PR1CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed